Andreas Scheel

9PUBLICATIONS
74CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 08, 2026
FIND: a phase-II study to evaluate the efficacy and safety of erdafitinib in FGFR-altered NSCLC.

|Mar 14, 2024
Evolutionary trajectories of small cell lung cancer under therapy.

Julie George, Lukas Maas, Nima Abedpour

|May 14, 2022
High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome.

Kerstin Menck, Darius Wlochowitz, Astrid Wachter

|Mar 29, 2021
High sensitivity of PD-L1 analysis from pleural effusion in nonsmall cell lung cancer.

Lars Hagmeyer, Stephan Schäfer, Marianne Engels

|Aug 07, 2019
"Interchangeability" of PD-L1 immunohistochemistry assays: a meta-analysis of diagnostic accuracy.

Emina Torlakovic, Hyun J Lim, Julien Adam

|Nov 09, 2018
Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors.

Jana Fassunke, Fabienne Müller, Marina Keul

Pageof 2

Frequent Collaborators

2 joint publications

Dennis Plenker

2 joint publications

Reinhard Büttner

2 joint publications

Roman K Thomas

2 joint publications

Martin Hellmich